InvestorsHub Logo
icon url

thekrup

06/12/09 4:53 PM

#1325 RE: kindo #1324

I believe they have until the first of July to come up with a plan and submit it to the exchange and then would have until Dec. 2010 to regain compliance if I read the 8-k correctly.

http://biz.yahoo.com/e/090602/anx8-k.html
icon url

powerbattles

06/14/09 2:12 AM

#1328 RE: kindo #1324

According to this old news state in second quarter of 2009
that would end in JUNE.
Adventrx Pharmaceuticals Inc has entered into an agreement with a new contract manufacturer to conduct process development and scale-up activities for both ANX-530 and ANX- 514. Last week, the Company attended a pre-NDA meeting with the U.S. Food and Drug Administration to discuss its NDA submission for ANX-530. The FDA requested additional information regarding the Companys new manufacturer, and as a result, ADVENTRX Pharmaceuticals, Inc anticipates the submission of its NDA for ANX-530 will take place in the second quarter of 2009.
icon url

powerbattles

06/14/09 3:19 AM

#1329 RE: kindo #1324

State is in second quarter of 2009

Adventrx Pharmaceuticals Inc has entered into an agreement with a new contract manufacturer to conduct process development and scale-up activities for both ANX-530 and ANX- 514. Last week, the Company attended a pre-NDA meeting with the U.S. Food and Drug Administration to discuss its NDA submission for ANX-530. The FDA requested additional information regarding the Companys new manufacturer, and as a result, ADVENTRX Pharmaceuticals, Inc anticipates the submission of its NDA for ANX-530 will take place in the second quarter of 2009

No effect on the Company's previously announced timelines

ADVENTRX's remaining employees will focus their efforts on continuing to evaluate strategic options, as well as continuing the Company's on-going bioequivalence study of ANX-514 (docetaxel emulsion) and activities related to submitting a New Drug Application for ANX-530 (vinorelbine emulsion). The cost-cutting measures announced today should not have a direct and immediate effect on the Company's previously announced timelines.

http://ir.adventrx.com/phoenix.zhtml?c=7...